BACKGROUND: Oropouche fever virus is an important arbovirus associated with febrile disease that re-emerged in 2006 in several municipalities of Pará State, Bragantina region, Amazon, Brazil, 26 years after the last epidemic. OBJECTIVE: To investigate an Oropouche fever outbreak in this region. STUDY DESIGN: A serologic survey and prospective study of acute febrile cases were performed in Magalhães Barata (urban and rural areas) and Maracanã (rural area) municipalities. Serology (IgM-ELISA and hemagglutination-inhibition [HI]), virus isolation, RT-PCR and real-time-PCR were used to confirm Oropouche virus (OROV) as responsible for the febrile outbreaks. RESULTS: Real-time-PCR showed high titers of OROV in acute-phase serum samples from febrile patients. From 113 of 119 acutely febrile patients with paired serum samples, OROV infections was confirmed by serologic conversion (n=76) or high titers (n=37) for both HI and IgM-ELISA. Patients had a febrile disease characterized by headache, chills, dizziness, photophobia, myalgia, nausea, and vomiting. Females and children under 15 years of age were most affected. Nucleotide sequencing of six OROV isolates identified that genotype II was associated with the human disease epidemic. CONCLUSIONS: Oropouche fever, which has re-emerged in the Bragantina region in eastern Amazon 26 years after the last epidemic, is caused by genotype II, a lineage previously found only in Peru and western Brazil.
BACKGROUND:Oropouche fever virus is an important arbovirus associated with febrile disease that re-emerged in 2006 in several municipalities of Pará State, Bragantina region, Amazon, Brazil, 26 years after the last epidemic. OBJECTIVE: To investigate an Oropouche fever outbreak in this region. STUDY DESIGN: A serologic survey and prospective study of acute febrile cases were performed in Magalhães Barata (urban and rural areas) and Maracanã (rural area) municipalities. Serology (IgM-ELISA and hemagglutination-inhibition [HI]), virus isolation, RT-PCR and real-time-PCR were used to confirm Oropouche virus (OROV) as responsible for the febrile outbreaks. RESULTS: Real-time-PCR showed high titers of OROV in acute-phase serum samples from febrile patients. From 113 of 119 acutely febrile patients with paired serum samples, OROV infections was confirmed by serologic conversion (n=76) or high titers (n=37) for both HI and IgM-ELISA. Patients had a febrile disease characterized by headache, chills, dizziness, photophobia, myalgia, nausea, and vomiting. Females and children under 15 years of age were most affected. Nucleotide sequencing of six OROV isolates identified that genotype II was associated with the human disease epidemic. CONCLUSIONS:Oropouche fever, which has re-emerged in the Bragantina region in eastern Amazon 26 years after the last epidemic, is caused by genotype II, a lineage previously found only in Peru and western Brazil.
Authors: Natasha L Tilston-Lunel; Gustavo Olszanski Acrani; Richard E Randall; Richard M Elliott Journal: J Virol Date: 2015-12-23 Impact factor: 5.103
Authors: Michele de Souza Bastos; Luiz Tadeu Moraes Figueiredo; Felipe Gomes Naveca; Rossicleia Lins Monte; Natália Lessa; Regina Maria Pinto de Figueiredo; João Bosco de Lima Gimaque; Guilherme Pivoto João; Rajendranath Ramasawmy; Maria Paula Gomes Mourão Journal: Am J Trop Med Hyg Date: 2012-04 Impact factor: 2.345
Authors: Juan-Carlos Navarro; Dileyvic Giambalvo; Rosa Hernandez; Albert J Auguste; Robert B Tesh; Scott C Weaver; Humberto Montañez; Jonathan Liria; Anderson Lima; Jorge Fernando Soares Travassos da Rosa; Sandro P da Silva; Janaina M Vasconcelos; Rodrigo Oliveira; João L S G Vianez; Marcio R T Nunes Journal: Am J Trop Med Hyg Date: 2016-05-23 Impact factor: 2.345
Authors: Helena Baldez Vasconcelos; Márcio R T Nunes; Lívia M N Casseb; Valéria L Carvalho; Eliana V Pinto da Silva; Mayra Silva; Samir M M Casseb; Pedro F C Vasconcelos Journal: Emerg Infect Dis Date: 2011-05 Impact factor: 6.883
Authors: Patricia V Aguilar; Alan D Barrett; Mohammad F Saeed; Douglas M Watts; Kevin Russell; Carolina Guevara; Julia S Ampuero; Luis Suarez; Manuel Cespedes; Joel M Montgomery; Eric S Halsey; Tadeusz J Kochel Journal: PLoS Negl Trop Dis Date: 2011-09-20
Authors: Kerstin Wernike; Emiliana Brocchi; Paolo Cordioli; Yann Sénéchal; Christian Schelp; Anne Wegelt; Andrea Aebischer; Gleyder Roman-Sosa; Ilona Reimann; Martin Beer Journal: Vet Res Date: 2015-03-11 Impact factor: 3.683
Authors: Chantal Reusken; Cees van den Wijngaard; Paul van Beek; Martin Beer; Ruth Bouwstra; Gert-Jan Godeke; Leslie Isken; Hans van den Kerkhof; Wilfrid van Pelt; Wim van der Poel; Johan Reimerink; Peter Schielen; Jonas Schmidt-Chanasit; Piet Vellema; Ankje de Vries; Inge Wouters; Marion Koopmans Journal: Emerg Infect Dis Date: 2012-11 Impact factor: 6.883
Authors: Maria Paula G Mourãão; Michelle S Bastos; João Boscoe L Gimaqu; Bruno Rafaelle Mota; Giselle S Souza; Gustavo Henrique N Grimmer; Elizabeth S Galusso; Eurico Arruda; Luiz Tadeu M Figueiredo Journal: Emerg Infect Dis Date: 2009-12 Impact factor: 6.883